Showing results (151-160 of 250) with videos related to

Sort By:
Pageof 25
Cardiovascular Drugs and Therapy|March 1, 1997
Systemic and regional hemodynamic effects of gallopamil in patients with essential hypertensionR G Ketelhut, F H Messerli, C Losem, et al.
The American Journal of Cardiology|June 15, 1997
Comparison of early target organ damage between blacks and whites with mild systemic arterial hypertensionR E Schmieder, J K Rockstroh, G Lüchters, et al.
The American Journal of Cardiology|March 1, 1985
Immediate hemodynamic effects of urapidil in patients with essential hypertensionI Kobrin, C Amodeo, H O Ventura, et al.
Cardiovascular Drugs and Therapy|December 1, 1987
Diltiazem maintains renal vasodilation without hyperfiltration in hypertension: studies in essential hypertension man and the spontaneously hypertensive ratT Isshiki, C Amodeo, F H Messerli, et al.
International Journal of Clinical Pharmacology and Biopharmacy|October 1, 1976
Effects of beta-adrenergic blockade on plasma cyclic AMP and blood sugar responses to glucagon and isoproterenol in manF H Messerli, O Kuchel, G Tolis, et al.
Journal of the American College of Cardiology|April 1, 1991
Immediate and short-term cardiovascular effects of fosinopril, a new angiotensin-converting enzyme inhibitor, in patients with essential hypertensionS Oren, F H Messerli, E Grossman, et al.
Circulation|December 1, 1988
Systemic and regional hemodynamic and humoral effects of nitrendipine in essential hypertensionE Grossman, S Oren, G E Garavaglia, et al.
American Journal of Hypertension|December 1, 1995
Gender-specific cardiovascular adaptation due to circadian blood pressure variations in essential hypertensionR E Schmieder, J K Rockstroh, F Aepfelbacher, et al.
European Heart Journal|December 1, 1989
Sex differences in cardiac adaptation to essential hypertensionG E Garavaglia, F H Messerli, R E Schmieder, et al.
The American Journal of Cardiology|April 1, 1985
Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (captopril) in essential hypertensionH O Ventura, E D Frohlich, F H Messerli, et al.
Pageof 25